基本信息
出版地:Netherlands
期刊简称:EBIOMEDICINE
通讯地址:RADARWEG 29, AMSTERDAM, NETHERLANDS, 1043 NX
创刊年份:2013
发行周期:12 issues/year
涉及方向:Biochemistry, Genetics and Molecular Biology - General Biochemistry,Genetics and Molecular Biology
ESSN:2352-3964
英文期刊简介
The effective translation of insights gained from biomedical research into improved human health is a global priority. To this end, Elsevier has looked to the leadership of its two leading brands, Cell and The Lancet, to guide the launch of a new comprehensive, online-only open access Elsevier journal, EBioMedicine, focused on forming a community that spans this interface and creates a valuable opportunity for dialogue and collaboration between their respective audiences.
中文期刊简介
《Ebiomedicine》是一本由ELSEVIER出版商出版的专业医学期刊,该刊创刊于2013年,刊期12 issues/year,该刊已被国际权威数据库SCIE收录。在中科院最新升级版分区表中,该刊分区信息为大类学科:医学 2区,小类学科:医学:研究与实验 2区;在JCR(Journal Citation Reports)分区等级为Q1。该刊发文范围涵盖医学:研究与实验等领域,旨在及时、准确、全面地报道国内外医学:研究与实验工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等,促进学术交流,鼓励学术创新。2021年影响因子为11.205,平均审稿速度5 Weeks。